Consistent with the use of RAS inhibitors, such as ACE inhibitors and angiotensin receptor blockers (ARBs), which are widely prescribed for the treatment of hypertension [27], our data demonstrate that inhibition of the classic RAS by STS-loaded NPs is associated with a BP-lowering effect. The gene discussed is ACE; the disease is Hypertension.